Financial Statements · Financial Reporting
AstraZeneca Eesti OÜ
Official identifier 11733875Record date 31 Dec 2021
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2021
- Period start
- 1 Jan 2021
- Submitted date
- 30 Jun 2022
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 3,189,226 |
| Balance sheet | Cash and cash equivalents | 2,487,865 |
| Balance sheet | Current assets | 3,163,707 |
| Balance sheet | Current liabilities | 752,326 |
| Balance sheet | Equity | 2,436,900 |
| Balance sheet | Share capital at nominal value | 690,246 |
| Balance sheet | Non-current assets | 25,519 |
| Balance sheet | Retained earnings (loss) from previous periods | 1,422,061 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -6,967 |
| Income statement scheme 1 | Labour costs | -2,049,168 |
| Income statement scheme 1 | Revenue | 3,045,823 |
| Income statement scheme 1 | Annual period profit / loss | 249,746 |
| Income statement scheme 1 | Operating profit (loss) | 249,750 |
| Income statement scheme 1 | Profit (loss) before income tax | 249,746 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 1,422,061 |
| Note: Labour costs | Employees | 29 |
| Note: Labour costs | Labour costs | 2,049,168 |
Linked company
Company: AstraZeneca Eesti OÜ